Portal de Periódicos da CAPES

Reply to a letter from Dr Drago

2014; Wiley; Volume: 41; Issue: 9 Linguagem: Inglês

10.1111/1346-8138.12561

1346-8138

Tsutomu Ohtsuka,

Microscopic Colitis

The Journal of DermatologyVolume 41, Issue 9 p. 865-866 Letter to the Editor Reply to a letter from Dr Drago Tsutomu Ohtsuka, Corresponding Author Tsutomu Ohtsuka Department of Dermatology, International University of Health and Welfare Hospital, Nasushiobara, JapanCorrespondence: Tsutomu Ohtsuka, M.D., Ph.D., Department of Dermatology, International University of Health and Welfare Hospital, 537-3, Iguchi Nasushiobara, Tochigi 329-2763, Japan. Email: [email protected]Search for more papers by this author Tsutomu Ohtsuka, Corresponding Author Tsutomu Ohtsuka Department of Dermatology, International University of Health and Welfare Hospital, Nasushiobara, JapanCorrespondence: Tsutomu Ohtsuka, M.D., Ph.D., Department of Dermatology, International University of Health and Welfare Hospital, 537-3, Iguchi Nasushiobara, Tochigi 329-2763, Japan. Email: [email protected]Search for more papers by this author First published: 03 September 2014 https://doi.org/10.1111/1346-8138.12561Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Lavagna A, Bergallo M, Daperno M et al. Infliximab and the risk of latent viruses reactivation in active Crohn's disease. Inflamm Bowel Dis 2007; 13: 896–902. 10.1002/ibd.20131 CASPubMedWeb of Science®Google Scholar 2Torre-Cisneros J, Del Castillo M, Castón JJ, Castro MC, Pérez V, Collantes E. Infliximab does not activate replication of lymphotropic herpesviruses in patients with refractory rheumatoid arthritis. Rheumatology (Oxford) 2005; 44: 1132–5113. 10.1093/rheumatology/keh696 CASPubMedWeb of Science®Google Scholar 3Collamer AN, Guerrero KT, Henning JS, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. Arthritis Rheum 2008; 59: 996–1001. 10.1002/art.23835 CASPubMedWeb of Science®Google Scholar 4Collamer AN, Battafarano DF. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis. Semin Arthritis Rheum 2010; 40: 233–240. 10.1016/j.semarthrit.2010.04.003 CASPubMedWeb of Science®Google Scholar Citing Literature Volume41, Issue9September 2014Pages 865-866 ReferencesRelatedInformation